Literature DB >> 12655259

Mutant p53 expression and apoptotic activity of Helicobacter pylori positive and negative gastritis in correlation with the presence of intestinal metaplasia.

Zsuzsa Unger1, Béla Molnár, László Prónai, Erika Szaleczky, Tamás Zágoni, Zsolt Tulassay.   

Abstract

BACKGROUND: Mutation of the p53 gene is detectable in most cases of gastric cancer, as it is the most common genetic alteration in human malignancies. It is also well documented that Helicobacter pylori infection plays an important role in gastric carcinogenesis. There is still no clarification, however, concerning how genetic instability influences the homeostasis of gastric epithelium. We have studied the effect of H. pylori infection on apoptosis of the antral epithelium in the presence/absence of intestinal metaplasia and the expression of the p53 oncoprotein. The relationship between these two processes is analysed.
METHODS: Antral biopsies were taken from 36 patients who underwent routine upper endoscopy (17 men, 19 women, mean age 61.0 years). The biopsies were fixed in formalin and embedded in paraffin. Patients were classified into two histological groups: (1) as chronic gastritis without intestinal metaplasia (n = 19), and (2) chronic gastritis with intestinal metaplasia (n = 17). An immunohistochemical method was used to detect the expression of p53 oncoprotein, and the terminal transferase mediated dUTP nick end-labelling (TUNEL) method was used to detect apoptotic cells.
RESULTS: In the absence of intestinal metaplasia, both the apoptotic index (0.0272 +/- 0.011 vs 0.0128 +/- 0.006) and expresssion of p53 (35.55 +/- 31.16 vs 18.33 +/- 19.65) were significantly higher in H. pylori positive cases compared to H. pylori negative cases. In the presence of intestinal metaplasia, p53 expression was further increased (P < 0.05), but apoptosis was similar to that observed in H. pylori negative gastritis without intestinal metaplasia. In the presence of intestinal metaplasia, H. pylori infection did not influence apoptosis (0.013 +/- 0.004 vs 0.011 +/- 0.004), or p53 ratio (70.16 +/- 22.54 vs 68.50 +/- 28.96). In the sequence of gastritis-intestinal metaplasia the two indices show a close negative correlation (P < 0.05).
CONCLUSION: In the absence of intestinal metaplasia H. pylori infection increases both apoptotic activity and expression of p53 oncoprotein in the gastric mucosa. The lack of increased apoptosis with a higher p53 expression in the presence of intestinal metaplasia suggests an increased genetic instability and also may suggest that mutation of the p53 gene is an early step in the multistep process of gastric carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12655259     DOI: 10.1097/00042737-200304000-00009

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  12 in total

1.  Detection of H. pylori antibody profile in serum by protein array.

Authors:  Feng-Chan Han; Xu-Jun Li; Hong Jiang; Li-Peng Qin; Ding Li; Yan-Hai Guo; Zhi-Guang Liu; Li Zhang; Xiao-Jun Yan
Journal:  World J Gastroenterol       Date:  2006-07-07       Impact factor: 5.742

2.  Regulation of p53 tumor suppressor by Helicobacter pylori in gastric epithelial cells.

Authors:  Jinxiong Wei; Toni A Nagy; Anna Vilgelm; Elena Zaika; Seth R Ogden; Judith Romero-Gallo; Maria B Piazuelo; Pelayo Correa; Mary K Washington; Wael El-Rifai; Richard M Peek; Alexander Zaika
Journal:  Gastroenterology       Date:  2010-06-12       Impact factor: 22.682

3.  Helicobacter pylori Infection Activates the Akt-Mdm2-p53 Signaling Pathway in Gastric Epithelial Cells.

Authors:  Xu Shu; Zhen Yang; Zhong-Hua Li; Lian Chen; Xiao-Dong Zhou; Yong Xie; Nong-Hua Lu
Journal:  Dig Dis Sci       Date:  2014-12-06       Impact factor: 3.199

4.  Identification of H. pylori strain specific DNA sequences between two clinical isolates from NUD and gastric ulcer by SSH.

Authors:  Feng-Chan Han; Min Gong; Han-Chong Ng; Bow Ho
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

5.  Genetic alterations in benign lesions: chronic gastritis and gastric ulcer.

Authors:  Ana Cristina Gobbo César; Marília de Freitas Calmon; Patrícia Maluf Cury; Alaor Caetano; Aldenis Albaneze Borim; Ana Elizabete Silva
Journal:  World J Gastroenterol       Date:  2006-01-28       Impact factor: 5.742

6.  Expression of mutant type-p53 products in H pylori-associated chronic gastritis.

Authors:  Masaaki Kodama; Kazunari Murakami; Tadayoshi Okimoto; Ryugo Sato; Koichiro Watanabe; Toshio Fujioka
Journal:  World J Gastroenterol       Date:  2007-03-14       Impact factor: 5.742

7.  Apoptotic cell death and its relationship to gastric carcinogenesis.

Authors:  Ferda Bir; Nese Calli-Demirkan; A Cevik Tufan; Metin Akbulut; N Lale Satiroglu-Tufan
Journal:  World J Gastroenterol       Date:  2007-06-21       Impact factor: 5.742

8.  The histological and immunohistochemical aspects of bile reflux in patients with gastroesophageal reflux disease.

Authors:  Andreas Nakos; Georgios Kouklakis; Michail Pitiakoudis; Petros Zezos; Eleni Efraimidou; Alexandra Giatromanolaki; Alexandros Polychronidis; Nikolaos Liratzopoulos; Efthimios Sivridis; Konstantinos Simopoulos
Journal:  Gastroenterol Res Pract       Date:  2011-07-24       Impact factor: 2.260

Review 9.  Genetic and molecular aspects of Helicobacter pylori in gastritis, pre- cancerous conditions and gastric adenocrcinoma.

Authors:  Mohammad Shadifar; Ramin Ataee; Amin Ataie; Ali Morad Heydari Gorgi; Nafiseh Nasri Nasrabadi; Somayyeh Nouri
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2015

Review 10.  Helicobacter pylori virulence factor CagA promotes tumorigenesis of gastric cancer via multiple signaling pathways.

Authors:  Xin Yong; Bo Tang; Bo-Sheng Li; Rui Xie; Chang-Jiang Hu; Gang Luo; Yong Qin; Hui Dong; Shi-Ming Yang
Journal:  Cell Commun Signal       Date:  2015-07-11       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.